http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017060290-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
filingDate 2016-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab7d0e0d4c78ba0a7e052fa0e9dcd380
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_367a43b238c92417a7468afbf8790abe
publicationDate 2017-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2017060290-A1
titleOfInvention Crystalline encenicline hydrochloride
abstract The present invention relates to a crystalline forms of encenicline hydrochloride and a process for their preparation. The invention also concerns a pharmaceutical compositions comprising an effective amount of the crystalline form of encenicline hydrochloride and at least one pharmaceutically acceptable excipient. The pharmaceutical composition of the present invention can be used as medicament, in particular for treatment and/or prevention of CNS disorders associated with cognitive deficits such as Alzheimer's disease and schizophrenia.
priorityDate 2015-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013169646-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2727604-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03055878-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011146511-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227030966
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46196517

Total number of triples: 33.